Tenon Medical is trading at $3.81, down 5.57%, with no clear company-specific catalyst identified for the October 2 decline.

  • Tenon Medical’s September 30 announcement of the SImmetry+ commercial launch and approximately $1.2 million in incremental revenue during its limited alpha launch was already public before this session; reports do not establish it as the cause of the drop.
  • Broader markets were higher, but available evidence does not clearly explain the move through market direction either.